Answers are grounded in this paper and cite their sources.
BackgroundDue to the low mutational testing rate in patients with Gastrointestinal Stromal Tumors (GIST), The Life Raft Group (LRG) conducted a survey to analyze various factors that may have an impact on patients’ ability to receive mutational testing. Methods A survey about mutational testing for patients with GIST, or their caregivers, was conducted by The Life Raft Group in June 2020 with 295 patients/caregivers participating. The Life Raft Group is a non-profit organization that provides support, advocacy, and conducts research for patients with GIST. The survey was designed by the LRG Patient Registry Department. Members of the LRG, regardless of Patient Registry status, were eligible to participate. ResultsThe percentage of patients who indicated they had received mutational testing was much higher in this survey than in the general GIST community. The LRG membership is voluntary and proactive; patients who join are more likely to participate in surveys and mutational testing. In this survey, 80% of patients reported a known mutation. Several reasons were cited for having a test, including: “My doctor ordered/suggested that I have it done” (54%); “The Life Raft Group advised/suggested I have it done” (25%); “I asked my doctor to have it done” (22%); “I had it done as part of a clinical trial” (5%); “I am not sure” (3%) and “Other” (14%). Mutational testing resulted in a treatment change in 25% of cases. ConclusionsA doctor’s order/recommendation was the most cited reason for patients receiving a mutational test (54%), highlighting the critical role that doctors play in whether a patient receives mutational testing. An LRG recommendation for testing (25%) and patient’s advocating for the test (22%) were the next most cited reasons. One of the most important findings was that mutational testing resulted in changes in treatment in 25% of cases. In other cases, it provided confidence in the current or proposed treatment plan. These are extremely important findings, as it helps ensure that patients are on the proper treatment, which should lead to better outcomes.
No takes yet. Share an insight, caveat, or question.
Montoya et al. (2021) studied this question.